Methods for treatment of oncological disorders using an epimetabolic shifter (coenzyme Q10)
US12209285B2 · kind B2 · utility
0Cited by
126References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 16, 2021 |
| Grant date | Jan 28, 2025 |
| Priority date | — |
| Expiry date | May 17, 2041 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and formulations for treating oncological disorders in humans using Coenzyme Q10 are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.